HK1211595A1 - Peptide - Google Patents

Peptide

Info

Publication number
HK1211595A1
HK1211595A1 HK15112228.2A HK15112228A HK1211595A1 HK 1211595 A1 HK1211595 A1 HK 1211595A1 HK 15112228 A HK15112228 A HK 15112228A HK 1211595 A1 HK1211595 A1 HK 1211595A1
Authority
HK
Hong Kong
Prior art keywords
peptide
Prior art date
Application number
HK15112228.2A
Other languages
English (en)
Inventor
David Wraith
Heather Streeter
Laurence Ordonez
Original Assignee
Apitope Int Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Int Nv filed Critical Apitope Int Nv
Publication of HK1211595A1 publication Critical patent/HK1211595A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Marine Sciences & Fisheries (AREA)
HK15112228.2A 2013-01-15 2015-12-11 Peptide HK1211595A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1300683.8A GB201300683D0 (en) 2013-01-15 2013-01-15 Peptide
PCT/IB2014/058234 WO2014111841A2 (en) 2013-01-15 2014-01-13 Peptide

Publications (1)

Publication Number Publication Date
HK1211595A1 true HK1211595A1 (en) 2016-05-27

Family

ID=47757994

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112228.2A HK1211595A1 (en) 2013-01-15 2015-12-11 Peptide

Country Status (21)

Country Link
US (4) US20150352197A1 (ko)
EP (1) EP2945965B8 (ko)
JP (2) JP6407888B2 (ko)
KR (1) KR102129763B1 (ko)
CN (1) CN105102477B (ko)
AU (1) AU2014206593B2 (ko)
CA (2) CA3154542A1 (ko)
DK (1) DK2945965T3 (ko)
ES (1) ES2694660T3 (ko)
GB (1) GB201300683D0 (ko)
HK (1) HK1211595A1 (ko)
HU (1) HUE040547T2 (ko)
IL (1) IL239870B (ko)
MX (1) MX369413B (ko)
PL (1) PL2945965T3 (ko)
PT (1) PT2945965T (ko)
RU (1) RU2667428C2 (ko)
SG (1) SG11201505530XA (ko)
TR (1) TR201815667T4 (ko)
WO (1) WO2014111841A2 (ko)
ZA (1) ZA201504986B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7419229B2 (ja) * 2017-08-14 2024-01-22 百明信康生物技術（浙江）有限公司 方法
EP4146190A2 (en) 2020-05-06 2023-03-15 Imcyse SA Combination treatment for fumarate-related diseases
AU2022286630A1 (en) 2021-06-01 2023-12-07 Imcyse Sa Improved methods of treatment using immunogenic peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US9340577B2 (en) * 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
IL117976A0 (en) * 1995-04-20 1996-08-04 Brigham & Womens Hospital Modulation of cytokine patterns of human autoreactive t-cell clones
EP0922057A1 (en) * 1996-03-28 1999-06-16 Immulogic Pharmaceutical Corporation Myelin oligodendrocyte glycoprotein peptides and uses thereof
EP1911461B1 (en) * 2000-10-19 2011-12-07 Epimmune Inc. HLA class I and II binding peptides and their uses
IL146016A0 (en) * 2001-10-17 2002-07-25 Yeda Res & Dev Synthetic peptides and dna sequences and compositions comprising them for treatment of multiple sclerosis
AU2005259991B2 (en) * 2004-06-25 2011-05-26 Id Biomedical Corporation Of Quebec Compositions and methods for treating neurological disorders
US8188218B2 (en) * 2006-10-27 2012-05-29 University Of Kansas Bi-functional peptides for multiple sclerosis treatment and diagnosis
EP2621522A2 (en) * 2010-09-27 2013-08-07 China Agricultural University Combined antigen and dna vaccine for preventing and treating autoimmune diseases

Also Published As

Publication number Publication date
DK2945965T3 (en) 2018-11-19
WO2014111841A2 (en) 2014-07-24
RU2667428C2 (ru) 2018-09-19
IL239870B (en) 2018-10-31
EP2945965B1 (en) 2018-07-25
US20150352197A1 (en) 2015-12-10
MX2015009086A (es) 2016-02-16
US20240148843A1 (en) 2024-05-09
KR102129763B1 (ko) 2020-07-03
CN105102477A (zh) 2015-11-25
EP2945965A2 (en) 2015-11-25
EP2945965B8 (en) 2018-09-05
US20190275126A1 (en) 2019-09-12
PL2945965T3 (pl) 2019-08-30
RU2015134357A (ru) 2017-02-22
MX369413B (es) 2019-11-07
JP6407888B2 (ja) 2018-10-17
IL239870A0 (en) 2015-08-31
CA3154542A1 (en) 2014-07-24
SG11201505530XA (en) 2015-08-28
CA2897894A1 (en) 2014-07-24
TR201815667T4 (tr) 2018-11-21
US20220016226A1 (en) 2022-01-20
WO2014111841A3 (en) 2014-10-30
ES2694660T3 (es) 2018-12-26
PT2945965T (pt) 2018-11-14
HUE040547T2 (hu) 2019-03-28
JP2018193390A (ja) 2018-12-06
ZA201504986B (en) 2019-04-24
GB201300683D0 (en) 2013-02-27
AU2014206593B2 (en) 2017-09-07
CA2897894C (en) 2022-06-21
AU2014206593A1 (en) 2015-07-23
CN105102477B (zh) 2019-03-19
JP2016504412A (ja) 2016-02-12
KR20150107766A (ko) 2015-09-23

Similar Documents

Publication Publication Date Title
HK1216757A1 (zh) 肽化合物
GB201311475D0 (en) Polypeptides
EP2989885A4 (en) COMBINE
HRP20180452T1 (hr) Peptidi
HUE050164T2 (hu) Új négy-CTL epitóp-kapcsolt peptid
HK1211596A1 (en) Peptide
GB201308057D0 (en) Protein
HK1198769A1 (en) Novel peptide
GB201309421D0 (en) Polypeptides
HK1211595A1 (en) Peptide
GB201315130D0 (en) Peptides
PL2983690T3 (pl) Peptydy pochodzące od neuropeptydu Y
GB201401955D0 (en) Protein
GB201316660D0 (en) Peptides
GB201300381D0 (en) Peptides
GB201305465D0 (en) Novel peptides
GB201322749D0 (en) Cyclic peptide
GB201302030D0 (en) Protein
GB201302031D0 (en) Protein